Publications

2022

  • Challenges of Antimicrobial Resistance and Stewardship in Solid Organ Transplant Patients.

So M, Walti L. Infect Dis Rep., 2022; 24: 63–75. https://doi.org/10.1007/s11908-022-00778-1

New icon.png
  • Bring it on: Top five antimicrobial stewardship challenges in transplant infectious diseases and practical strategies to address them

So M, Tsai H, Swaminathan N, & Bartash R. Antimicrob Steward Healthc Epidemiol, 2022; 2(1): E72.

https://doi.org/10.1017/ash.2022.53

New icon.png
  • Evaluation of different antimicrobial stewardship models at a rehabilitation hospital: An interrupted time series (ITS) study. 

Curran J, Leis J, Robinson L, et al. Antimicrob Steward Healthc Epidemiol, 2(1): E45. 

https://doi.org/10.1017/ash.2022.1

  • How generalizable are randomized controlled trials (RCTs) in Staphylococcus aureus bacteremia? A description of the mortality gap between RCTs and observational studies.

Bai, AD, Lo CKL, Komorowski AS, Suresh M, Guo K, Garg A, Tandon P, Senecal J, Del Corpo O, Stefanova I, Fogarty C, Butler-Laporte G, McDonald EG, Cheng MP, Morris AM, Loeb M, Lee TC, Clin Infect Dis, 2022: ciac177.

https://doi.org/10.1093/cid/ciac177

  • The feasibility and generalizability of assessing the appropriateness of antimicrobial prescribing in hospitals: a review of the Australian National Antimicrobial Prescribing Survey 

James R, Nakamachi Y, Morris AM, So M, et al. JAC-Antimicrobial Resistance, 2022;4(1): dlac012. 

https://doi.org/10.1093/jacamr/dlac012

  • Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond retrospective, controlled study. 

Goff D, Gauthier TP, Langford BJ, Prusakov P, Chukwuema MU, Nwomeh BC, Yunis KA, Saad T, van den Bergh D, Villegas MV, Martinez N, Morris AM, Ashiru-Oredope D, Howard P, Sanchez PJ.  Journal of the American College of Pharmacy, 2022.[Epub] 

https://doi.org/10.1002/jac5.1622

  • Patterns of Antimicrobial Use in an Outpatient Hemodialysis Unit.

Sivarajahkumar S, So M, Morris AM, Lok C, Bell CM, Battistella M. Can J Hosp Pharm. 2022;75(1):15-20.

https://doi.org/10.4212/cjhp.v75i1.3250

  • Antibiotic prescribing patterns among patients admitted to an academic teaching hospital for COVID-19 during the first wave of the pandemic in Toronto: A retrospective, controlled study. 

So M, Morris A, Walker AM. JAMMI, 2022; 7(1): 14-22.

https://doi.org/10.3138/jammi-2021-0020

  • The Harms of Postoperative Antibiotic Prophylaxis: A Teachable Moment.

Halani S, McIntyre M, Vaisman A. JAMA Intern Med, 2022.[Epub] 

https://doi.org/10.1001/jamainternmed.2022.0413

  • Outpatient Therapies for COVID-19: How Do We Choose?

Lee TC, Morris AM, Grover SA, Murthy S, McDonald EG. Open Forum Infect Dis., 2022;9(3):ofac008

https://doi.org/10.1093/ofid/ofac008

Abstracts

Use of Nudging Strategies to Develop a Clinical Microbiology Antimicrobial Stewardship Framework.

McIntyre M, Langford BJ, Leung E et al. European Congress of Clinical Microbiology and Infectious Diseases 2022.

A national survey of antimicrobial stewardship content in Canadian Undergraduate Pharmacy Programs.

Sauve J, Dresser L, Rocchi M, So M. Canadian Society of Hospital Pharmacists 2022

Building Consensus on Antimicrobial Stewardship Nudges. 

McIntyre M, Langford BJ, Leung E et al. Association of Medical Microbiology and Infectious Diseases Canada 2022.

Increasing Perioperative Cefazolin Utilization for Surgical Site Infection Prophylaxis in β-Lactam Allergic Patients: An interrupted time-series study.

Vaisman A, McIntyre M, Wong DT, Neilson C, Lui Pj, Jackson T, Esmail T. Gobin I. Canadian Anesthesiologists' Society 2022

 

2021

  • ​Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression. 

Langford BJ, So M et al. Clin Microbiol Infect, 2021;S1198-743X(21)00636-4. https://doi.org/10.1016/j.cmi.2021.11.008

  • Characterizing the inclusion of pregnant and breastfeeding people in infectious diseases randomized controlled trials: a targeted literature review.

Wu JH, Khalid F, Langford BJ, Beahm NP, McIntyre M, Schwartz KL, Garber G, Leung V. Can Pharm J (Ott). 2021;154(3):179-192.
https://doi.org/10.1177/1715163521999417.

  • The Impact of COVID-19 on Outpatient Antibiotic Prescriptions in Ontario, Canada; An Interrupted Time Series Analysis. 

Kitano T, Brown KA, Daneman N, MacFadden DR, Langford BJ, Leung V, So M, et al. Open Forum Infect Dis. 2021;8(11): ofab533.

https://doi.org/10.1093/ofid/ofab533

Abstracts

Comparing All-Cause to Procedure-Related Mortality in Cardiac Implantable Electronic Device (CIED) Lead Removals: A Systematic Review.

Herman J, Somanader D, Ishaq L, Abdelaal A, Mehra V, Ramendra E, Morris AM. American Heart Association. 2021.

Nudging in MicroBiology Laboratory Evaluation (NIMBLE): Developing a Framework for Microbiology Nudging Interventions.

Matukas L, Langford, BJ, Leung E, McIntyre M. Nudges in Healthcare Symposium 2021.

Success and Complication Rates in Cardiac Implantable Electronic Device (CIED) Laser Lead Extractions: A Systematic Review

Mehra V, Herman JE, Somanader D, Ishaq L, Abdelaal A, Ramendra R, Morris AM, American Heart Association, 2021.

2020

  • Presence of urinary symptoms in bacteremic urinary tract infection: a retrospective cohort study of Escherichia coli bacteremia.

Bai AD, Bonares MJ, Thrall S, Bell C, Morris AM. BMC Infect Dis, 2020; 20: 781
https://doi.org/10.1186/s12879-020-05499-1

  • Variation in antibiotic use across intensive care units (ICU): A population-based cohort study in Ontario, Canada

Lee EY, Detsky ME, Ma J, Bell CM, Morris AM. Infect Control Hosp Epidemiol, 2020;41(9):1035-1041.
https://doi.org/10.1017/ice.2020.217

  • Bacterial Co-Infection and Secondary Infection in Patients with COVID-19: A Living Rapid Review and Meta-Analysis.

Langford BJ, So M, Raybardhan S, et al. Clin Microbiol Infect., 2020;26(12):1622-1629.
https://doi.org/10.1016/j.cmi.2020.07.016.

  • Should Therapeutic Monitoring of Vancomycin Based on Area under the Curve, Become Standard Practice for Patients with Confirmed or Suspected Methicillin-Resistant Staphylococcus aureus Infection?

Claeys KC, Brade KD, Heil EL, Jorgensen SCJ. Can J Hosp Pharm, 2020; 73(3)
https://doi.org/10.4212/cjhp.v73i3.3003

  • Governing Antimicrobial Resistance: A Narrative Review of Global Governance Mechanisms. 

Ruckert A, Fafard P, Hindmarch S, Morris AMJ Public Health Policy, 2020;41(4):515-528.
https://doi.org/10.1057/s41271-020-00248-9

  • Evaluating the Effect of Nurse Initiated Discussion of Infection Management during ICU Bedside Rounds.

 Dresser L, McIntyre M, Jorgoni L, Stephenson A, Nelson S, Jorgensen S, Bell CM, Morris AM.  Published at BMJ Open Quality: https://bmjopenquality.bmj.com/content/9/4/e001037  

  • Bacterial Co-Infection and Secondary Infection in Patients with COVID-19: A Living Rapid Review and Meta-Analysis.

  • Baricitinib: impact on COVID-19 coagulopathy?

 Jorgensen SCJ, Burry L, Tse CY, Dresser LD. Clinical Infectious Diseases. [E Pub 14 Aug 2020]

  • Vancomycin AUC-guided therapeutic drug monitoring to reduce nephrotoxicity: are we overlooking a simpler solution?

Jorgensen SCJ, Stewart JS, Dalton B. International Journal of Antimicrobial Chemotherapy. [E Pub 31 Aug 2020]

  •  A Canadian Perspective on the Revised 2020 ASHP/IDSA/PIDS/SIDP Guidelines for Vancomycin AUC-Based Therapeutic Drug Monitoring for Serious MRSA Infections.

Stewart JS, Jorgensen SCJ, Dresser LD, Lau TTY, Gin A, Thirion DJG, Nishi C, Dalton B. Accepted at JAMMI.

  • Remdesivir: A review of pharmacology, pre-clinical data and clinical experience for COVID-19. 

Jorgensen SCJ, Kebriaei R, Dresser LD. Accepted at Pharmacotherapy.

  •  Antiviral Therapy during the Coronavirus Disease (COVID-19) Pandemic: Is It Appropriate to Treat Patients in the Absence of Significant Evidence?

  • Evaluating and Prioritizing Antimicrobial Stewardship Programs for Nursing Homes: A Modified Delphi Panel.

Kruger SZ, Bronskill SE, Jeffs L, Steinberg M, Morris AM, Bell CM. Accepted at ICHE

Langford B, So M, Raybardhan S, Leung V, Westwood D, MacFadden D, Soucy J, Daneman N. 
Published in CMI.
https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30423-7/fulltext

  • Community Pharmacist Prescribing of Antimicrobials: A Systematic Review from an Antimicrobial Stewardship Perspective.

 Leung V, Langford B, McIntyre M, Khalid F, Wu JCH, et al. Accepted at Canadian Pharmacists Journal.

  • Development and evaluation of a primary care antimicrobial stewardship program (PC-ASP) in Toronto, Canada.

McIsaac W, Morris, A et al. Accepted at JAMMI.

  • Baricitinib:  review of pharmacology, safety and emerging clinical experience for COVID-19.

Jorgensen SCJ, Tse CLY, Burry L, Dresser LD.  Published at Pharmacotherapy. https://accpjournals.onlinelibrary.wiley.com/doi/abs/10.1002/phar.2438

  • Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study-

 Published in CID
https://academic.oup.com/cid/article-abstract/71/1/1/5548921?redirectedFrom=fulltext

  • Counterpoint: Vancomycin AUC-based therapeutic drug monitoring should NOT become standard for patients with confirmed or suspected methicillin-resistant Staphylococcal aureus infections.

Jorgensen SCJ, Dresser LD, Dalton B. Accepted at CJHP.

  • "Finding the relevance of antimicrobial stewardship for cystic fibrosis."

 Cogen, J. D., B. C. Kahl, H. Maples, S. A. McColley, J. A. Roberts, K. L. Winthrop, A. M. Morris, A. Holmes, P. A. Flume, D. R. VanDevanter, V. Waters, M. S. Muhlebach, J. S. Elborn, L. Saiman and S. C. Bell (2020). Journal of Cystic Fibrosis.

  • "A behavioural approach to specifying interventions: what insights can be gained for the reporting and implementation of interventions to reduce antibiotic use in hospitals?"

  • Unnecessary antibiotic prescribing in a Canadian primary care setting: a descriptive analysis using routinely collected electronic medical record data. 

Schwartz KL, Langford BJ, Daneman N, Chen B, Brown KA, McIsaac W, Tu K, Candido E et al. CMAJ Open 2020. E360-E369. 

Duncan, E. M., E. Charani, J. E. Clarkson, J. J. Francis, K. Gillies, J. M. Grimshaw, W. V. Kern, F. Lorencatto, C. A. Marwick, J. McEwen, R. Mohler, A. M. Morris, C. R. Ramsay, S. Rogers Van Katwyk, M. Rzewuska, B. Skodvin, I. Smith, K. N. Suh and P. G. Davey (2020). J Antimicrob Chemother.

  • Defining appropriate antibiotic prescribing in primary care: a modified Delphi panel approach.

 Hui-Chih J, Langford B, Ha R, Garber G, Daneman N, Johnstone J, McIsaac W, Sharpe S, Tu K, Schwartz KL. JAMMI 2020.

  • Unnecessary antibiotic prescribing in a Canadian primary care setting: a descriptive analysis using routinely collected electronic medical record data. 

Schwartz KL, Langford BJ, Daneman N, Chen B, Brown KA, McIsaac W, Tu K, Candido E et al. CMAJ Open 2020. E360-E369. 

  • Nudging In MicroBiology Laboratory Evaluation (NIMBLE): A scoping review. 

Langford BJ, Leung E, Haj R, McIntyre M, Taggart LR, Brown KA, Downing M, Matukas LM. Infec Control Hosp Epidemiol. 2019 Dec; 40(12): 1400-1406. 

  • Bacterial Co-Infection and Secondary Infection in Patients with COVID-19: A Living Rapid Review and Meta-Analysis. Published in CMI.

Langford B, So M, Raybardhan S, Leung V, Westwood D, MacFadden D, Soucy J, Daneman N. https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30423-7/fulltext

Abstracts

Title: Declining rates of AOM in British Columbia: the impact of pneumococcal conjugate vaccines
on disease burden and antibiotic use.

Saatchi A, Khatri Vadlamudi N, Patrick DM, Morris AM, Silverman M, Sadarangani M, Marra F.